|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [sodium arsenite results in decreased activity of ACHE protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased activity of ACHE protein] |
CTD |
PMID:32392679 PMID:33497687 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
AKR1B1 |
aldo-keto reductase family 1 member B |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in increased expression of AKR1B1 mRNA] |
CTD |
PMID:22687555 |
|
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
|
|
G |
APP |
amyloid beta precursor protein |
multiple interactions |
EXP |
Gallic Acid inhibits the reaction [protocatechuic acid inhibits the reaction [APP protein modified form binds to APP protein modified form]]; protocatechuic acid inhibits the reaction [APP protein modified form binds to APP protein modified form] |
CTD |
PMID:22129351 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
ASS1 |
argininosuccinate synthase 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of ASS1 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of BAX mRNA]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of BAX protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of BAX mRNA]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of BAX protein] |
CTD |
PMID:32392679 PMID:33497687 PMID:36593721 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein]; protocatechuic acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]; protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] |
CTD |
PMID:18082360 PMID:32392679 PMID:33497687 PMID:36593721 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BDNF |
brain derived neurotrophic factor |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of BDNF protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BDNF protein] |
CTD |
PMID:32392679 PMID:33497687 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 mRNA]; protocatechuic acid inhibits the reaction [furan results in increased activity of CASP3 protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]; protocatechuic acid inhibits the reaction [Rotenone results in increased activity of CASP3 protein] protocatechuic acid inhibits the reaction [sodium arsenite results in increased activity of CASP3 protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of CASP3 mRNA] |
CTD |
PMID:18082360 PMID:32392679 PMID:32758512 PMID:33497687 PMID:36593721 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [furan results in increased activity of CASP9 protein] |
CTD |
PMID:32758512 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
increases activity multiple interactions |
ISO |
protocatechuic acid results in increased activity of CAT protein protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of CAT mRNA]; protocatechuic acid inhibits the reaction [furan results in decreased activity of CAT protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased activity of CAT protein] protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of CAT protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of CAT mRNA] |
CTD |
PMID:29842870 PMID:32392679 PMID:32758512 PMID:33497687 PMID:36593721 PMID:36807594 More...
|
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] |
CTD |
PMID:31306686 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression |
ISO |
protocatechuic acid results in increased expression of CDKN1A protein |
CTD |
PMID:16227210 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
COMT |
catechol-O-methyltransferase |
increases methylation |
EXP ISO |
COMT protein results in increased methylation of protocatechuic acid |
CTD |
PMID:11160877 |
|
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
|
|
G |
CS |
citrate synthase |
increases activity |
ISO |
protocatechuic acid results in increased activity of CS protein |
CTD |
PMID:31306686 |
|
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
|
|
G |
CYP11A1 |
cytochrome P450 family 11 subfamily A member 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of CYP11A1 mRNA]; protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of CYP11A1 protein] |
CTD |
PMID:37105472 |
|
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
|
|
G |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of CYP17A1 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of CYP19A1 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein] |
CTD |
PMID:15302093 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] |
CTD |
PMID:15302093 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
multiple interactions decreases activity |
ISO |
[protocatechuic acid co-treated with Methylcholanthrene] results in decreased activity of CYP2E1 protein; protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of CYP2E1 mRNA] protocatechuic acid results in decreased activity of CYP2E1 protein |
CTD |
PMID:15302093 PMID:37105472 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYP7B1 |
cytochrome P450 family 7 subfamily B member 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of CYP7B1 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
|
|
G |
DKK2 |
dickkopf WNT signaling pathway inhibitor 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of DKK2 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 4:106,921,802...107,036,313
Ensembl chr 4:106,921,802...107,283,806
|
|
G |
EFNA2 |
ephrin A2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of EFNA2 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr19:1,284,227...1,301,431
Ensembl chr19:1,285,873...1,301,431
|
|
G |
ENO1 |
enolase 1 |
increases expression |
EXP |
protocatechuic acid results in increased expression of ENO1 mRNA |
CTD |
PMID:16227210 |
|
NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
|
|
G |
EPO |
erythropoietin |
multiple interactions increases expression |
ISO |
protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of EPO protein]; protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of EPO protein] protocatechuic acid results in increased expression of EPO protein |
CTD |
PMID:31850806 PMID:32461003 |
|
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A binds to ESR1 protein] |
CTD |
PMID:37105472 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ESR2 |
estrogen receptor 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A binds to ESR2 protein] |
CTD |
PMID:37105472 |
|
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
increases expression multiple interactions |
ISO |
protocatechuic acid results in increased expression of FSHB protein protocatechuic acid inhibits the reaction [furan results in decreased expression of FSHB protein] |
CTD |
PMID:29842870 PMID:32758512 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
increases activity multiple interactions |
ISO |
protocatechuic acid results in increased activity of G6PD protein protocatechuic acid inhibits the reaction [furan results in decreased activity of G6PD protein] |
CTD |
PMID:29842870 PMID:32758512 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GLO1 |
glyoxalase I |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in decreased expression of and results in decreased activity of GLO1 protein] |
CTD |
PMID:22687555 |
|
NCBI chr 6:38,675,925...38,703,145
Ensembl chr 6:38,675,925...38,703,145
|
|
G |
GPX1 |
glutathione peroxidase 1 |
increases expression multiple interactions |
ISO |
protocatechuic acid results in increased expression of GPX1 mRNA protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of GPX1 mRNA] protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of GPX1 mRNA] |
CTD |
PMID:32392679 PMID:33497687 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GSR |
glutathione-disulfide reductase |
increases expression multiple interactions increases activity |
ISO |
protocatechuic acid results in increased expression of GSR mRNA protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of GSR mRNA]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased activity of GSR protein] protocatechuic acid results in increased activity of GSR protein protocatechuic acid inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of GSR mRNA] |
CTD |
PMID:32392679 PMID:33497687 PMID:36593721 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
increases stability increases expression multiple interactions |
ISO |
protocatechuic acid results in increased stability of HIF1A protein protocatechuic acid results in increased expression of HIF1A protein protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of HIF1A protein]; protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of HIF1A protein] |
CTD |
PMID:16227210 PMID:31850806 PMID:32461003 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of HMOX1 mRNA] protocatechuic acid results in increased expression of HMOX1 mRNA |
CTD |
PMID:36593721 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HSD17B11 |
hydroxysteroid 17-beta dehydrogenase 11 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of HSD17B11 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 4:87,336,515...87,391,188
Ensembl chr 4:87,336,515...87,391,188
|
|
G |
HSD17B3 |
hydroxysteroid 17-beta dehydrogenase 3 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 9:96,235,306...96,302,176
Ensembl chr 9:96,235,306...96,302,176
|
|
G |
HSD3B1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of HSD3B1 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
|
|
G |
HSD3B2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of HSD3B2 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 1:119,414,931...119,423,034
Ensembl chr 1:119,414,931...119,423,035
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IKBKB protein] |
CTD |
PMID:36807594 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [furan results in decreased expression of IL10 protein] |
CTD |
PMID:32758512 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL1B protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of IL1B mRNA]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of IL1B protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of IL1B mRNA]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of IL1B protein]; protocatechuic acid inhibits the reaction [furan results in increased expression of IL1B protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of IL1B protein] |
CTD |
PMID:22687555 PMID:32392679 PMID:32758512 PMID:33497687 PMID:36593721 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL6 protein] |
CTD |
PMID:22687555 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
LDHC |
lactate dehydrogenase C |
increases activity |
ISO |
protocatechuic acid results in increased activity of LDHC protein |
CTD |
PMID:29842870 |
|
NCBI chr11:18,412,318...18,452,063
Ensembl chr11:18,412,318...18,452,063
|
|
G |
LHB |
luteinizing hormone subunit beta |
increases expression multiple interactions |
ISO |
protocatechuic acid results in increased expression of LHB protein protocatechuic acid inhibits the reaction [furan results in decreased expression of LHB protein] |
CTD |
PMID:29842870 PMID:32758512 |
|
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein] |
CTD |
PMID:36807594 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK3 protein] |
CTD |
PMID:36807594 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MPO |
myeloperoxidase |
increases activity multiple interactions decreases activity |
EXP ISO |
protocatechuic acid results in increased activity of MPO protein protocatechuic acid inhibits the reaction [furan results in increased activity of MPO protein] protocatechuic acid results in decreased activity of MPO protein |
CTD |
PMID:24060682 PMID:29842870 PMID:32758512 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression |
ISO |
[protocatechuic acid co-treated with Cadmium Chloride] results in increased expression of NFE2L2 mRNA; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 mRNA] protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 mRNA] protocatechuic acid results in increased expression of NFE2L2 mRNA |
CTD |
PMID:32392679 PMID:36593721 PMID:36807594 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKBIB |
NFKB inhibitor beta |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of NFKBIB protein] |
CTD |
PMID:20026373 |
|
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] which results in increased abundance of Nitrites]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of NOS2 mRNA]; protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 mRNA] |
CTD |
PMID:20026373 PMID:31306686 PMID:32392679 PMID:33497687 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases activity |
ISO |
[protocatechuic acid co-treated with Methylcholanthrene] results in increased activity of NQO1 protein protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of NQO1 mRNA] protocatechuic acid results in increased activity of NQO1 protein |
CTD |
PMID:15302093 PMID:36807594 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
OXTR |
oxytocin receptor |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of OXTR mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 3:8,741,269...8,769,613
Ensembl chr 3:8,750,381...8,769,628
|
|
G |
PITX1 |
paired like homeodomain 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of PITX1 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 5:135,027,734...135,034,789
Ensembl chr 5:135,027,734...135,034,813
|
|
G |
PRL |
prolactin |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [furan results in decreased expression of PRL protein] |
CTD |
PMID:32758512 |
|
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 protein]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of PTGS2 protein]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of PTGS2 protein] |
CTD |
PMID:20026373 PMID:22687555 PMID:31306686 PMID:36807594 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in increased expression of and results in increased activity of RELA protein]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA protein]; protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of RELA protein] |
CTD |
PMID:20026373 PMID:22687555 PMID:36593721 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SCARB1 |
scavenger receptor class B member 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of SCARB1 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
|
|
G |
SELE |
selectin E |
multiple interactions |
EXP |
protocatechuic acid inhibits the reaction [TNF protein results in increased expression of SELE protein] |
CTD |
PMID:30611791 |
|
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
increases expression multiple interactions |
ISO |
protocatechuic acid results in increased expression of SLC2A1 protein protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein]; protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of SLC2A1 protein] |
CTD |
PMID:31850806 PMID:32461003 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SOD2 |
superoxide dismutase 2 |
increases expression multiple interactions |
ISO |
protocatechuic acid results in increased expression of SOD2 mRNA protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of SOD2 mRNA] protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mRNA] |
CTD |
PMID:32392679 PMID:33497687 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
STAR |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of STAR mRNA]; protocatechuic acid inhibits the reaction [bisphenol A results in decreased expression of STAR protein] |
CTD |
PMID:37105472 |
|
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
|
|
G |
STMN2 |
stathmin 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of STMN2 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 8:79,611,117...79,666,158
Ensembl chr 8:79,611,117...79,666,158
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of TGFB1 protein] |
CTD |
PMID:36593721 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TLR4 |
toll like receptor 4 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
CTD |
PMID:36807594 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO EXP |
protocatechuic acid inhibits the reaction [Galactose results in increased secretion of TNF protein]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of TNF mRNA]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of TNF protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of TNF mRNA]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of TNF protein]; protocatechuic acid inhibits the reaction [furan results in increased expression of TNF protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of TNF protein] protocatechuic acid inhibits the reaction [TNF protein results in increased expression of SELE protein] |
CTD |
PMID:22687555 PMID:30611791 PMID:31306686 PMID:32392679 PMID:32758512 PMID:33497687 PMID:36593721 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
UGT2A3 |
UDP glucuronosyltransferase family 2 member A3 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of UGT2A3 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 4:68,928,463...68,951,804
Ensembl chr 4:68,928,463...68,951,804
|
|
G |
ULBP1 |
UL16 binding protein 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of ULBP1 mRNA] |
CTD |
PMID:37105472 |
|
NCBI chr 6:149,963,943...149,973,715
Ensembl chr 6:149,963,943...149,973,715
|
|
G |
VEGFA |
vascular endothelial growth factor A |
increases expression multiple interactions |
ISO |
protocatechuic acid results in increased expression of VEGFA protein protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of VEGFA protein]; protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of VEGFA protein] |
CTD |
PMID:16227210 PMID:31850806 PMID:32461003 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
FABP4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of FABP4 mRNA] |
CTD |
PMID:24338020 |
|
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
|
|
G |
GATA3 |
GATA binding protein 3 |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased ubiquitination of and results in increased degradation of GATA3 protein] |
CTD |
PMID:24338020 |
|
NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
|
|
G |
KLF2 |
KLF transcription factor 2 |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased ubiquitination of and results in increased degradation of KLF2 protein] |
CTD |
PMID:24338020 |
|
NCBI chr19:16,324,826...16,328,685
Ensembl chr19:16,324,826...16,328,685
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA] |
CTD |
PMID:24338020 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
SP7 |
Sp7 transcription factor |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [Ascorbic Acid results in increased expression of SP7 mRNA]; ethyl protocatechuate inhibits the reaction [Ascorbic Acid results in increased expression of SP7 protein] |
CTD |
PMID:21467157 |
|
NCBI chr12:53,326,575...53,344,793
Ensembl chr12:53,326,575...53,345,315
|
|
G |
TAFAZZIN |
tafazzin, phospholipid-lysophospholipid transacylase |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [Rosiglitazone results in increased ubiquitination of and results in increased degradation of TAFAZZIN protein] |
CTD |
PMID:24338020 |
|
NCBI chr X:154,411,539...154,421,726
Ensembl chr X:154,411,524...154,421,726
|
|
|
G |
ACADL |
acyl-CoA dehydrogenase long chain |
increases expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate results in increased expression of ACADL mRNA |
CTD |
PMID:32389661 |
|
NCBI chr 2:210,187,923...210,225,447
Ensembl chr 2:210,187,126...210,225,447
|
|
G |
ACADM |
acyl-CoA dehydrogenase medium chain |
decreases expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate results in decreased expression of ACADM mRNA |
CTD |
PMID:32389661 |
|
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575
|
|
G |
ACADVL |
acyl-CoA dehydrogenase very long chain |
affects expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate affects the expression of ACADVL mRNA |
CTD |
PMID:32389661 |
|
NCBI chr17:7,217,125...7,225,266
Ensembl chr17:7,217,125...7,225,266
|
|
G |
ACOX1 |
acyl-CoA oxidase 1 |
affects expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate affects the expression of ACOX1 mRNA |
CTD |
PMID:32389661 |
|
NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177
|
|
G |
CPT1B |
carnitine palmitoyltransferase 1B |
decreases expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate results in decreased expression of CPT1B mRNA |
CTD |
PMID:32389661 |
|
NCBI chr22:50,568,861...50,578,612
Ensembl chr22:50,568,861...50,578,465
|
|
G |
CPT1C |
carnitine palmitoyltransferase 1C |
decreases expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate results in decreased expression of CPT1C mRNA |
CTD |
PMID:32389661 |
|
NCBI chr19:49,690,662...49,713,731
Ensembl chr19:49,690,898...49,713,731
|
|
G |
HK1 |
hexokinase 1 |
increases expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate results in increased expression of HK1 mRNA |
CTD |
PMID:32389661 |
|
NCBI chr10:69,270,000...69,401,882
Ensembl chr10:69,269,984...69,401,884
|
|
G |
PDK1 |
pyruvate dehydrogenase kinase 1 |
increases expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate results in increased expression of PDK1 mRNA |
CTD |
PMID:32389661 |
|
NCBI chr 2:172,555,373...172,724,312
Ensembl chr 2:172,555,373...172,608,669
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
affects expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate affects the expression of PPARA mRNA |
CTD |
PMID:32389661 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
decreases expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate results in decreased expression of PPARGC1A mRNA |
CTD |
PMID:27559315 PMID:32389661 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
PPARGC1B |
PPARG coactivator 1 beta |
affects expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate affects the expression of PPARGC1B mRNA |
CTD |
PMID:27559315 |
|
NCBI chr 5:149,730,310...149,857,959
Ensembl chr 5:149,730,298...149,855,022
|
|
G |
SLC22A5 |
solute carrier family 22 member 5 |
increases uptake |
EXP ISO |
SLC22A5 protein results in increased uptake of 3-(2,2,2-trimethylhydrazine)propionate |
CTD |
PMID:18981167 |
|
NCBI chr 5:132,369,710...132,395,612
Ensembl chr 5:132,369,710...132,395,613
|
|
G |
SLC2A4 |
solute carrier family 2 member 4 |
increases expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate results in increased expression of SLC2A4 mRNA |
CTD |
PMID:32389661 |
|
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
|
|
G |
SLC5A2 |
solute carrier family 5 member 2 |
affects expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate affects the expression of SLC5A2 mRNA |
CTD |
PMID:32389661 |
|
NCBI chr16:31,483,123...31,490,769
Ensembl chr16:31,483,002...31,490,860
|
|
G |
TFAM |
transcription factor A, mitochondrial |
decreases expression |
ISO |
3-(2,2,2-trimethylhydrazine)propionate results in decreased expression of TFAM mRNA |
CTD |
PMID:27559315 |
|
NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
|
|
|
G |
ATG5 |
autophagy related 5 |
multiple interactions |
ISO |
roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of ATG5 protein] |
CTD |
PMID:27082295 |
|
NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
|
|
G |
BNIP3 |
BCL2 interacting protein 3 |
multiple interactions |
ISO |
roxadustat promotes the reaction [Hyaluronic Acid results in increased expression of BNIP3 protein] |
CTD |
PMID:27082295 |
|
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
increases activity multiple interactions |
EXP ISO |
roxadustat results in increased activity of HIF1A protein [Cadmium Chloride results in increased abundance of Cadmium] inhibits the reaction [roxadustat results in increased activity of HIF1A protein] roxadustat promotes the reaction [Hyaluronic Acid results in increased expression of HIF1A protein] |
CTD |
PMID:27082295 PMID:29741670 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HK2 |
hexokinase 2 |
increases expression |
EXP |
roxadustat results in increased expression of HK2 mRNA |
CTD |
PMID:33596451 |
|
NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359
|
|
G |
LDHA |
lactate dehydrogenase A |
increases expression |
EXP |
roxadustat results in increased expression of LDHA mRNA |
CTD |
PMID:33596451 |
|
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of MAP1LC3B protein] |
CTD |
PMID:27082295 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
increases expression |
EXP |
roxadustat results in increased expression of SLC2A1 mRNA |
CTD |
PMID:33596451 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|